Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532771 | NSE Symbol : JHS | ISIN : INE544H01014 | Industry : Personal Care - Indian |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
29-Apr-2025	29-Apr-2025	Change in Directors	Intimation of Re-appointment of Independent Director. Intimation of Re-appointment of Mr. Rajagopal Chakravarthi Venkateish and Mr. Kapil Minocha (DIN: 02817283), as an Independent Director with effect from June 23, 2025, for the term of five years, subject to approval of shareholders
06-Feb-2025	11-Feb-2025	Quarterly Results	Quarterly Results JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve the Un-Audited Financials Statement for the quarter and nine months ended December 31, 2024. (As per BSE Announcement Dated on 06/02/2025) Outcome of Board Meeting held on 11th February, 2025 to consider and approve the Un-audited Financial Results for the quarter and nine months ended December 31, 2024. (As Per BSE Announcement dated on 11.02.2025)
08-Jan-2025	08-Jan-2025	Amendments in Articles of Assoc.	Board of Director in its meeting held on 08 January, 2025 adopted the New Set of Article of Association as per Companies Act, 2013.
07-Nov-2024	13-Nov-2024	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2024. Outcome of Board Meeting Held on 13th November, 2024 for considered and approved the Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended 30th September, 2024. (As Per BSE Announcement dated on 13.11.2024)
06-Aug-2024	12-Aug-2024	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the un-audited Financial Results (standalone and consolidated) for the quarter ended 30th June 2024. JHS informed the exchange regarding the consideration and approval of Financials Results (Standalone and Consolidated) for the quarter ended 30th June, 2024 at its Board Meeting held on 12th August, 2024. (As Per BSE Announcement Dated on: 12/08/2024) Machine Readable and Searchable Financial Results for the Quarter ended June 30, 2024. (As Per BSE Announcement Dated on 17.08.2024)
03-Aug-2024	03-Aug-2024	Preferential Issue	JHS hereby inform the exchange that the Board of Directors at their meeting held on August 03, 2024, has considered and approved the allotment of equity shares and Fully convertible warrants.
30-May-2024	04-Jun-2024	Preferential Issue	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2024 inter alia to consider and approve To consider and approve the proposal of raising of funds by way of issue of one or more instruments THE BOARD IN ITS MEEETING APPROVED PREF ISSUE OF EQUITY SHARES & WARRANTS (As Per BSE Announcement Dated on: 04/06/2024)
10-May-2024	18-May-2024	Accounts	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve the Audited Financial Results for the Quarter and Year ended March 31 2024. Outcome of the Board Meeting Held on 18th May, 2024 for the approval of Audited Financial Results for the Year Ended March 31, 2024. Financial Results for the Quarter and Year Ended 31st March, 2024. Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform that the board considered and approved acquisition of 100 % Equity shares of subsidiary. Appointment of Secretarial Auditor for the year 2024-2025. (As Per BSE Announcement Dated on 18/05/2024)
05-Feb-2024	14-Feb-2024	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. The Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on December 312023. 2. Any other Permitted by the Chair. JHS Svendgaard Laboratories Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on Wednesday, February 14th, 2024, inter-alia considered and approved the Un-audited Financial Results of the Company (Standalone as well as Consolidated) for the quarter and nine months ended 31st December, 2023 and took note of the Limited Review Report as provided by the Auditors. (As per BSE Announcement Dated on 14/02/2024)
31-Oct-2023	07-Nov-2023	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Un-Audited Financial Result (Standalone & Consolidated) of the Company for the quarter and half year ended on September 30 2023. JHS has informed that Board of Directors at their meeting held on Tuesday, November 7th, 2023, inter-alia considered and approved the shifting of registered office of the Company from the state of Himachal Pradesh to National Capital Territory of Delhi and Haryana and consequent alteration of the clause II i.e., Registered Office Clause of Memorandum of Association of the Company, subject to the approval of shareholders and requisite regulatory authorities. JHS Svendgaard Laboratories Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on Tuesday, November 07th, 2023, inter-alia considered and approved the Un-audited Financial Results of the Company (Standalone as well as Consolidated) for the quarter and half year ended 30th September, 2023 and took note of the Limited Review Report as provided by the Auditors (As Per BSE Announcement Dated on 07/11/2023)
22-Sep-2023	22-Sep-2023	Scheme of Amalgamation	The Board of Directors of the company in their meeting held today has considered and approved the scheme of arrangement for amalgamation of JHS Svendgaard Laboratories Limited with Vedic cosmeceuticals private Limited on going concern basis under the provisions of 230-232 of the Companies Act 2013 and rules made hereunder.
12-Sep-2023	12-Sep-2023	Scheme of Arrangement	This is to inform regarding Allotment of equity shares by the Company pursuant to Composite Scheme of Arrangement amongst JHS Svendgaard Retail Ventures Pvt. Ltd. (Resulting Company), JHS Svendgaard Brands Limited (Transferor Company) and JHS Svendgaard Laboratories Limited (Demerged Company) that Board of Directors in its meeting held today i.e September 12, 2023 has allotted 1,34,96,297 equity shares of INR 10/- each to the shareholders of the Transferor Company whose names appears in Register of Members of the Transferor Company as on the Effective date of the Scheme i.e August 28, 2023.
07-Aug-2023	14-Aug-2023	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Monday the 14th day of August 2023 at 12:00 P.M. to inter-alia consider and approve the following- a. Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30 2023. b. Limited Review Report issued by Statutory Auditors for such Financial Results. Board of directors of the company approved today unaudited Financial Results for the quarter ended 30th June 2023 (As Per BSE Announcement Dated on 14.08.2023) JHS Svendgaard Laboratories in their board meeting discussed and analyzed proposal for consolidation of business of company and vedic cosmeceuticals pvt ltd (As Per BSE Announcement Dated on 15/08/2023)
24-May-2023	30-May-2023	Accounts	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Audited Standalone & Consolidated Financial Results for the quarter and year ended March 31 2023. In terms of above referred provisions, this is to inform that the Board of Directors of the Company at their meeting held on Tuesday May 30th, 2023, inter-alia considered and approved Audited Financial Results for the Quarter and year ended March 31, 2023, and took note of the Auditor's Report issued by the Statutory Auditors on the said results. (As Per BSE Announcement Dated on 30.05.2023)
07-Feb-2023	14-Feb-2023	Quarterly Results	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday the 14th day of February 2023 at 12:00 Noon to inter-alia consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31 2022. The Board of Directors of JHS Svendgaard Laboratories Limited ('the Company') at their meeting held on today i.e. 14th February 2023, inter-alia, considered and approved, the Unaudited Financial Results (Standalone as well as Consolidated) for the quarter and nine months ended 31st December 2022. Outcome of the Board Meeting held on February 14, 2023 (As per BSE Announcement Dated on 14/02/2023) Pursuant to provisions of Regulation 33 and 47(3) read with Schedule III of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015. ('Listing regulations') the Board of Directors in its meeting held on 14th February, 2023 considered and approved the Un-audited (Standalone and Consolidated) Financial results for the quarter and nine months ended December 31, 2022. Further the extract of the Financial Results, according to Regulation 47 of listing regulations, were published on 15th February 2023, in Business Standard (English) and Business Standard (Hindi). (As Per BSE Announcement dated on 15.02.2023)

1 2

LOGIN HERE

JHS Svendgaard Laboratories Ltd

Board Meeting